BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
105 hedge funds and large institutions have $124M invested in BioDelivery Sciences International, Inc. in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 29 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
17% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 35
17% less funds holding
Funds holding: 126 → 105 (-21)
41% less capital invested
Capital invested by funds: $209M → $124M (-$84.7M)
69% less call options, than puts
Call options by funds: $743K | Put options by funds: $2.43M
72% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
Engaged Capital
Newport Beach,
California
|
+$6.93M |
| 2 |
Millennium Management
New York
|
+$3.83M |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$2.89M |
| 4 |
FPC
Falcon Point Capital
San Francisco,
California
|
+$2.28M |
| 5 |
B
Bailard
Foster City,
California
|
+$2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.1M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.51M |
| 3 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$6.3M |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$4.32M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$3.37M |
BDSI Hedge Fund Activity: Q1 2016 in Review
105 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q1 2016, worth a combined $124M — down 41% from $209M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of BDSI and 8 opened new positions — a net loss of 21 holders — while 35 trimmed existing stakes and 41 added.
The largest buyer was Engaged Capital, opening a new position worth an estimated $6.93M. The largest seller was Fidelity Investments, cutting an estimated $8.1M.
- 105 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q1 2016, down from 126 in Q4 2015.
- Funds reported $124M of BioDelivery Sciences International, Inc. stock for Q1 2016, down 41% quarter-over-quarter.
- 8 funds opened new BioDelivery Sciences International, Inc. positions in Q1 2016 and 29 closed out, a net change of -21 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q1 2016 was Engaged Capital, an estimated $6.93M added.
- The largest BioDelivery Sciences International, Inc. seller in Q1 2016 was Fidelity Investments, an estimated $8.1M sold.
Based on aggregated 13F filings for Q1 2016.